Belgium· BE-AMP-SAM096537-00
Polydexa 10 mg/ml - 1 mg/ml
A dexamethason und antiinfektiva product containing neomycin sulfate, registered in Belgium by Therabel Pharma. The same ATC class is registered in 6 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Dexamethason und antiinfektiva is registered in 6 of 19 countries.
Countries holding a registration under ATC S02CA06 (dexamethason und antiinfektiva), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Dexamethason und antiinfektiva · ATC S02CA06
6 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Netherlands
- Polandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Neomycin Sulfate
- Manufacturer
- Therabel Pharma
- Country
- Belgium (BE)
- ATC code
- S02CA06
- ATC class
- Dexamethason und Antiinfektiva
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb0070441
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dexamethason und antiinfektiva in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAntibioticTotal Resources International
- United KingdomCicatrin creamGlaxoSmithKline UK Ltd
- GermanyMyacyneMaxmedic Pharma Gmbh.
- PolandNeomycinum JelfaBausch+Lomb Ireland Ltd.
- CanadaNEOPRO 325CAN-VET ANIMAL HEALTH SUPPLIES LTD.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Germany · Myacyne, Neomycinsulfat Smartpractice Europe
- Spain · Neomicina
- Poland · Neomycinum, Neomycinum Tzf
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1d0bc39e-0543-44d5-8cd2-964747c44ff8 GET /v1/drugs/1d0bc39e-0543-44d5-8cd2-964747c44ff8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Ear drops, solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Polydexa 10 mg/ml - 1 mg/ml",
"name_fr": "Polydexa 10 mg/ml - 1 mg/ml",
"name_nl": "Polydexa 10 mg/ml - 1 mg/ml",
"amp_code": "SAM096537-00",
"strengths": [
"10.0000",
"10.0000",
"1.0000",
"1.0000",
"10000.0000",
"10000.0000",
"2.5000",
"3.0000",
"2.0000"
],
"pack_count": 1,
"substances": [
"Neomycin Sulfate",
"Dexamethasone Sodium Metasulfobenzoate",
"Polymyxin B Sulfate",
"Sodium Hydroxide",
"Thiomersal",
"Polysorbate 80"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Dexamethasone and Antiinfectives",
"authorisation_numbers": [
"BE096537"
]
}See everything about dexamethason und antiinfektiva.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.